October 12, 2022
Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors
Read More
June 30, 2022
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform
Read More
May 19, 2022
Inceptor Bio Announces $37 Million Series A Financing
Read More
December 16, 2021
Inceptor Bio Enters into In-licensing Agreement For CAR-M Platform
Read More
October 27, 2021
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio
Read More
June 14, 2021
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Read More